Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ark Invest purchases $5.5 million worth of Circle stock

Ark Invest purchases $5.5 million worth of Circle stock

Odaily星球日报Odaily星球日报2026/05/12 03:28
Show original

Odaily reported that Ark Invest purchased a total of 41,904 shares of Circle stock through three ETFs, worth 5.5 million USD. This is its first Circle purchase since March 24. Currently, Circle’s market value in ARKK holdings is 306.5 million USD, in ARKW is 82.3 million USD, and in ARKF is 56 million USD.

Circle announced its first quarter financial report, with total revenue reaching 694 million USD, up 20% year-on-year, while net profit dropped to 55 million USD. On-chain USDC transaction volume reached 21.5 trillion USD, and circulation reached 77 billion USD. Circle’s stock price rose 15.91% to 131.76 USD.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53